XNAS: CLLS
Cellectis (ADR) Live Stock Price Today, Share Analysis and Chart
about
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the fi...
Read More
1.51
-0.02
(-1.31%)
88,887
XNAS Volume
High vol.+loss this week
XNAS 21 Sep, 2026 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Bearish
Weak Stock
These stocks have poor scores across the board. Investors should be very cautious with these stocks
View Similar
Embed DVM
Cellectis (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..